Consistent with our transcriptomic findings (Fig. 3A), these IHC results provide protein-level validation of this gene signature, which support the roles of risk genes in tumor progression and the potential tumor-suppressive effect of SPOCK2, thereby highlighting their relevance to OSCC prognosis and therapeutic stratification. This evidence concerns the gene SPOCK2 and neoplasm.